Arjun Balar at [NYU Langone Medical Center]

Arjun V. Balar, MD

  • Specialty: Oncology
  • Language: English

About Me

Conditions and Treatments

adrenal tumor, bladder cancer, testicular cancer, prostate cancer, kidney cancer, cancer chemotherapy, immunotherapy
Learn more about conditions we treat at NYU Langone:
Prostate Cancer, Adrenal Tumors

Credentials

Positions

  • Assistant Professor, Department of Medicine
  • Co-Leader Genitourinary Cancers Program

Board Certifications

    2012
  • AB Internal Medicine (Medical Oncology)
    2010
  • AB Internal Medicine - Internal Medicine

Education and Training

  • 2012
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Medical Oncology
  • Fellowship, MEMORIAL SLOAN-KETTERING CANCER CENTER, Medical Oncology
  • 2009
  • Residency, Columbia Presbyterian Medical Center, Internal Medicine
  • 2009
  • Residency, New York Presbyterian-Weill Cornell Med Ctr, Internal Medicine
  • 2006
  • MD from University Of South Florida

Departments

Locations and Appointments

60 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MultiPlan/PHCS PPO
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

NYU Medical Oncology Associates
160 East 34th Street
New York, NY 10016

Contact

Phone: 212-731-5820

NYU Urology Associates
135 East 31st Street, 2nd Floor
New York, NY 10016

Contact

Phone: 646-825-6300

Request an Appointment

NYU Medical Oncology Associates
550 1st Avenue
New York, NY 10016

Contact

Phone: 212-652-1922

NYU Urology Associates
150 East 32nd Street, 2nd Floor
New York, NY 10016

Contact

Phone: 646-825-6300

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

The primary focus of my research is in development of new therapeutic strategies for patients with prostate, kidney and bladder cancers using novel, molecularly targeted medications. Through design and conduct of clinical trials, our team aims to improve upon the current standards of care with a focus on developing better tolerated and personalized treatments. In addition, I lead the NYU Genitourinary Oncology Tumor Registry which is a multidisciplinary effort involving clinical, basic science and translational researchers to characterize the genomic and molecular make up of genitourinary tumors and to better understand its impact on patient outcomes. Our aim is to study impact of these genetic and molecular factors on the clinical course of our patients and their response to the therapies we administer. Ultimately, our work may lay the foundation for a more individualized approach to our patients' care.

Publications

  • Cytotoxic and DNA-targeted therapy in urothelial cancer: Have we squeezed the lemon enough?

    Balar, Arjun V; Milowsky, Matthew I 2015 Jan; 179-187, Cancer — id: 1459682, year: 2015, page: 179, stat: Journal Article
  • The impact of taxanes on the management of genitourinary cancers

    Balar, Arjun V 2014 May; 555-560, Anti-cancer drugs — id: 1019322, year: 2014, page: 555, stat: Journal Article
  • Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness

    Rosenkrantz, Andrew B; Obele, Chika; Rusinek, Henry; Balar, Arjun V; Huang, William C; Deng, Fang-Ming; Ream, Justin M 2014 Aug; 45-56, Abdominal imaging — id: 1141422, year: 2014, page: 45, stat: JOURNAL ARTICLE
Read All Publications (10)